Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis.
Carmela NappiMichele KlainValeria CantoniRoberta GreenLeandra PiscopoFabio VolpeSimone MaureaMario PetrettaAlberto CuocoloPublished in: European journal of nuclear medicine and molecular imaging (2021)
The present meta-analysis indicates that patients with DTC treated with RAI do not have a higher risk of primary breast cancer compared to those not treated with RAI. These findings suggest that RAI therapy does not increase the risk of breast cancer.